Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Furberg

Showing results (81-90 of 205) with videos related to

Pageof 21
Sort By:
Cardiovascular Clinics|January 1, 1985
Beta-adrenergic blockers in the prevention of sudden deathW H Frishman, L I Laifer, C D Furberg
The American Journal of Medicine|April 17, 1989
Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research GroupC D Furberg, R P Byington, N A Borhani
Clinical Pharmacology and Therapeutics|June 1, 1987
Survival analysis of adverse effects data in the Beta-Blocker Heart Attack TrialB R Davis, C D Furberg, C B Williams
JAMA|May 30, 1998
Time to act on drug safetyT J Moore, B M Psaty, C D Furberg
Lancet (London, England)|October 8, 1999
Are drugs within a class interchangeable?C D Furberg, D M Herrington, B M Psaty
Nederlands Tijdschrift Voor Geneeskunde|April 27, 1996
[Calcium antagonists: safe or unsafe?]F R Rosendaal, B M Psaty, C D Furberg
Atherosclerosis|July 25, 1998
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials dataJ R Crouse, R P Byington, C D Furberg
Stroke|April 1, 1988
Relation between blood lipids, lipoproteins, and cerebrovascular atherosclerosis. A reviewG S Tell, J R Crouse, C D Furberg
Circulation|September 1, 1995
Nifedipine. Dose-related increase in mortality in patients with coronary heart diseaseC D Furberg, B M Psaty, J V Meyer
The New England Journal of Medicine|March 29, 1984
Beta-adrenergic blockade for survivors of acute myocardial infarctionW H Frishman, C D Furberg, W T Friedewald
Pageof 21

Showing results (81-90 of 205) with videos related to

Sort By:
Pageof 21
Cardiovascular Clinics|January 1, 1985
Beta-adrenergic blockers in the prevention of sudden deathW H Frishman, L I Laifer, C D Furberg
The American Journal of Medicine|April 17, 1989
Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research GroupC D Furberg, R P Byington, N A Borhani
Clinical Pharmacology and Therapeutics|June 1, 1987
Survival analysis of adverse effects data in the Beta-Blocker Heart Attack TrialB R Davis, C D Furberg, C B Williams
JAMA|May 30, 1998
Time to act on drug safetyT J Moore, B M Psaty, C D Furberg
Lancet (London, England)|October 8, 1999
Are drugs within a class interchangeable?C D Furberg, D M Herrington, B M Psaty
Nederlands Tijdschrift Voor Geneeskunde|April 27, 1996
[Calcium antagonists: safe or unsafe?]F R Rosendaal, B M Psaty, C D Furberg
Atherosclerosis|July 25, 1998
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials dataJ R Crouse, R P Byington, C D Furberg
Stroke|April 1, 1988
Relation between blood lipids, lipoproteins, and cerebrovascular atherosclerosis. A reviewG S Tell, J R Crouse, C D Furberg
Circulation|September 1, 1995
Nifedipine. Dose-related increase in mortality in patients with coronary heart diseaseC D Furberg, B M Psaty, J V Meyer
The New England Journal of Medicine|March 29, 1984
Beta-adrenergic blockade for survivors of acute myocardial infarctionW H Frishman, C D Furberg, W T Friedewald
Pageof 21